Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox in Pediatric Migraine
NCT03055767Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Mar 2017
- Primary completion
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in migraine, sponsored by University of California, Irvine. Started Mar 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03055767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03055767.